Skip to content

Human Tropical Fever IgM Lateral flow dipstick kit 7873

$487.00

Summary

  • Mikrogen diagnostik lateral flow device (dipstick) for research use (RUO)
  • Human Tropical Fever IgM Lateral flow dipstick kit 7873
  • Suitable for IgG detection
  • Ready-to-use
  • 20 tests
Weight1 lbs
Dimensions9 × 5 × 2 in
target

Human Tropical Fever (Chikungunya Virus, Dengue fever virus, Zikavirus) IgM

species reactivity

Chikungunya Virus, Dengue fever virus, Zikavirus

applications

Lateral flow (dipstick)

assay type

Indirect & qualitative

available sizes

20 test kits

Human Tropical Fever IgM Lateral flow dipstick kit 7873

kit
Assay type
Sandwich assay, lateral flow (dipstick)
Research area
Infectious Disease
Sample type
Serum, plasma, whole blood
Components
10X Wash Buffer100 mL
TMB Substrate40 mL
Milk Powder5 g
Instructions for Use1 Each
Evaluation Form1 Each
Test Strips2 kits of [2 Vials x 10 Each]
Anti-Human IgM Conjugate500 μL
Positive Control140 μL
Negative Control140 μL
Storage
Store at 2-8°C.
Additional information
Mikrogen recomLine Tropical Fever Test

The Mikrogen recomLine Tropical Fever tests are serological, qualitative line immunoassays that combine the diagnostic markers Equad proteins and non-structural proteins (NS1), thereby enabling the identification of specific antibodies against the individual antigens of Dengue, Chikungunya, and Zika viruses. Virus-like particles (VLP) are used to detect CHIKV and NS1 and Equad proteins are used for DENV and ZIKV. The unique setup allows differentiation of DENV and ZIKV using a 2-step interpretation scheme that includes NS1 antigen reactions and, in their absence, reactivities against Equad proteins.

Advantages
  • New antigens: higher sensitivity due to CHIKV VLP, DENV and ZIKV Equad as well as improved flavivirus differentiation.
  • Simultaneous detection and differentiation of DENV, CHIKV, and ZIKV infections in one step.
  • Parallel detection of IgG and IgM enables monitoring of seroconversions and supports diagnosis of both primary and secondary flavivirus infections.
  • Additional diagnostic support to reliably exclude ZIKV infections in pregnant women.
  • For human serum/plasma from approximately 7 days after symptom onset and for follow-up samples after 1-2 weeks.
  • Easy and clear interpretation due to two-band criterion.
  • Partial and full automation, software-based evaluation (recomScan), and integration with the laboratory information system are possible.
  • High sensitivity and specificity due to the use of recombinant antigens.
Bands
Antigen BandsDescription
DENV NS1Dengue non-structural protein 1 (1st stage differentiation)
DENV EquadVariant d. dengue envelope protein with targeted mutations to increase specificity (2nd stage differentiation)
CHIKV VLPChikungunya virus-like particles
ZIKV NS1Zika non-structural protein 1 (1st stage differentiation)
ZIKV EquadVariant d. Zika envelope protein with targeted mutations to increase specificity (2nd stage differentiation)
No information
target relevance

Publications

pmidtitleauthorscitation
We haven't added any publications to our database yet.
Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from PubMed database provided by The United States National Library of Medicine at the National Institutes of Health.

relevant to this product
7873 protocol
#
Please enter your product and batch number here to retrieve product datasheet, SDS, and QC information.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.